ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.25
0.00 (0.00%)
16 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.25 1.10 1.40 1.25 1.25 1.25 0.00 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -3.57 1.69M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.25p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.10p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £1.69 million. Physiomics has a price to earnings ratio (PE ratio) of -3.57.

Physiomics Share Discussion Threads

Showing 27726 to 27745 of 30150 messages
Chat Pages: Latest  1110  1109  1108  1107  1106  1105  1104  1103  1102  1101  1100  1099  Older
DateSubjectAuthorDiscuss
20/12/2020
13:14
Some comments based off this week's Hybridan Research Note

Phenomenal week of news for PYC for both the core Modelling and Simulation / Biosimulation business and the new blue sky exciting growth area of Personalised Precision Medicine

1. UK Government funding of £150k for a Precision Dosing App trial with Portsmouth NHS Technology Trials Unit

2. Merck sign up for £270k of 'initial' Modelling and Simulation contracts for 2021

3. Physiomics sign partnership deal with $1bn US Company Tabula Rasa Healthcare (TRHC) to commercialise Precision Dosing App in the huge US market



Some interesting numbers here on potential of US Precision Dosing market opportunity just in Prostate Cancer !

170,000 Prostate Cancer cases p.a. in US
20-30% advanced metastatic with only 30% 5 year survival rate
So an addressable market of 34,000 to 51,000
Exposure controlled dosing could help significant proportion in terms of survival and toxic side effects
Question becomes how much do TRHC/PYC charge for access to this software ?
At a very reasonable $100 per 'test' you'd be looking at revenues of $3.4m to $5.1 p.a.
I'd guess TRHC take majority of revenues whilst PYC get a royalty of say 10% ?
$0.34m-0.51m on a 50x multiple for 'high quality' royalty earnings stream basis could be worth $17-25m in valuation terms

Note RENX pricing for their CKD test is set at $950 a go so my numbers could be out by 10x !

Given a course of docetaxel can cost several thousand dollars maybe PYC/TRHC could justify that sort of rate in which case you're looking at potential market size of $34-51m and a PYC valuation of $170-250m !




Finally on the 'old core Modelling and Simulation' side of the business the IPO of Certara CERT has demonstrated the value the US market places on such businesses

PYC has circa £1m revenue per annum so on 25x revenue the 'unexciting' old core business should be valued at £25m !

Add the blue sky exciting Personalised Medicine business with a very conservative valuation of $17-25m (but with huge upside potential depending on how this scales up) we should be sitting at around £37.5m - £40m IMO

i.e. around 40p per share

the stigologist
19/12/2020
17:13
I don’t look at lse.
albert3591
19/12/2020
17:00
13 and counting on lse, or did you want that here
dubian99
19/12/2020
16:52
Forgot to say well done boris for doing the right thing this afternoon
albert3591
19/12/2020
14:38
Not often a $1 Billion Company with $300m annual revenues gushes about a deal with a £6m Company with £1m revenues... but note how Tabula Rasa TRHC have 2 of their Execs on this RNS
the stigologist
18/12/2020
23:31
Mark, why would they regret anything.

They can buy in again you know...you do realise the price is going down right?

People don't just take profits and run away, never to return lol

davevt
18/12/2020
23:06
I think people have ‘easily’ forgotten yesterday...
For what it was...
Ask anyone at 10p plus..?

maddie275
18/12/2020
22:18
It will come good.
bobby.ifa
18/12/2020
20:02
I think people have quickly forgotten yesterday's news, took some profit but will regret the bigger picture unfolding in front of us! IMO
markth126
18/12/2020
16:07
As I said earlier, verging on ‘criminal̵7; that so many minor, private investors will now be ‘locked’ in at a considerable loss due to MMs highly dubious... no, down right, deceitful activities..!
Feel for them/us...
Although... I blame ONLY myself for not taking 50%+ profits..!
Again..!!!!!

maddie275
18/12/2020
15:53
Where's Stig? 🤣🤣🤣
davevt
18/12/2020
15:35
Selling SNG to buy this you’re mad!!
chesty1
18/12/2020
15:04
Well didn't think the stars would align like this but managed to sell some SNG and bought again here thank you.
markth126
18/12/2020
14:35
What has expert industry knowledge got anything to do with knowing about buying and selling shares?

I mean look, at the price, I'm right, and Mr 'industry knowledge' is wrong.

davevt
18/12/2020
14:35
Mr Ali will be filling his boots no doubt
dubian99
18/12/2020
13:20
Tr1 - are you saying he hasn't got Expert industry knowledge or 'something', not insider knowledge, or is it you with Expert knowledge,

weekly rise and falls of aim shares are disconnected from incremental progress they make over months and years, comes a point when anyone with any brains understands the culmination of progress, News and indicated deals breaks that pattern or creates a buyer mkt,
your obviously bitter and fixated spamming everywhere

dubian99
18/12/2020
12:18
dubian...this share has had loads of tr1s and always plummets.

Why do people think if they see someone doing a tr1 that they must know something? They are as clueless as the rest of you.

davevt
18/12/2020
11:57
Hence why your a bb moron and the ex AstraZeneca director has a TR1
dubian99
18/12/2020
11:50
I value PYC at 3.5p
valuetracker
18/12/2020
11:42
Bye bye profits..!
It was nice to make your brief acquaintance..!!!

maddie275
Chat Pages: Latest  1110  1109  1108  1107  1106  1105  1104  1103  1102  1101  1100  1099  Older

Your Recent History

Delayed Upgrade Clock